Ortivus AB (publ) interim report for the period July – September 2022

2022-11-11 08:30:00

Ortivus continues to gain market share and component shortages affect deliveries

Highlights July - September 2022

  • Ortivus received an order for updated hardware to the ambulance service in Northern Ireland, which has been the company’s customer since 2019. The order value is estimated to 3.2 MSEK.
  • Region Blekinge awards Ortivus a contract on new equipment for the region’s ambulance operations to a value of 4.5 MSEK.
  • Region Gävleborg’s ambulance and hospital services awards Ortivus a contract regarding the delivery of Ortivus’ solution MobiMed Life and the order value is estimated to 4.0 MSEK.

Significant events after end of the period

  • Ortivus entered into a strategic distribution agreement with the Spanish company ITURRI, a well-established supplier to several sectors such as healthcare and the defense industry.
  • Ortivus communicates the start-up of a Danish subsidiary, Ortivus MobiMed ApS.


July - September 2022

  • Net sales amounted to 20.2 (24.5) MSEK.
  • The gross margin amounted to 44% (51%).
  • Profit after tax amounted to 0.2 (2.7) MSEK.
  • Earnings after tax per share before and after dilution amounted to 0.01 (0.06) SEK.
  • Operating cash flow before changes in working capital amounted to -8.0 (12.2) MSEK.

January - September 2022

  • Net sales amounted to 71.2 (71.7) MSEK.
  • The gross margin amounted to 50% (50%).
  • Profit after tax amounted to 5.7 (7.6) MSEK.
  • Earnings after tax per share before and after dilution amounted to 0.13 (0.17) SEK.
  • Operating cash flow before changes in working capital amounted to -8.8 (13.8) MSEK.

Jul-Sep 2022Jul-Sep 2021Jan-Sep 2022Jan-Sep 2021Jan-Dec 2021
Net sales (MSEK)20.224.571.271.794.3
Gross margin (%)44%51%50%50%51%
Operating profit (MSEK)0.02.75.57.69.3
Operating margin (%)0%11%8%11%10%
EBITDA (MSEK)2.13.19.18.212.7

MFN